ATT Stock Analysis: Attendo (publ) | ST
Medical Care Facilities | ST, Sweden | Market Cap: 16.525m SEK | 12M Return: 74.9% | SE0007666110 | Charts, Fundamentals & Technical Analysis
Avg Turnover: 22.7M
EPS Trend: 98.0%
Qual. Beats: 4
Rev. Trend: 83.1%
Qual. Beats: 0
Warnings
Tailwinds
Seasonality 10.5 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
Attendo AB is a Sweden-based provider of health and care services operating primarily in Scandinavia and Finland. The company delivers a broad portfolio that includes nursing homes for elderly and dementia patients, home care services, disability care, social psychiatry and psychosocial support, residential and supported housing, schools, and various staffing and temporary accommodation services. Founded in 1985 and headquartered in Danderyd, Attendo is listed on Nasdaq Stockholm under the ticker ATT and operates within the Health Care Facilities sub-industry.
The Nordic care services model is characterized by tax-funded provision by municipalities and regions, with Attendo acting as a private operator delivering services under public contracts. Demand for elderly care, disability services, and home-based care in Scandinavia and Finland is structurally supported by aging demographics and rising rates of cognitive and chronic conditions, though the sector is also subject to public budget constraints and regulatory oversight on quality and staffing levels.
- Nordic aging demographics fuel long-term care demand growth
- Staffing cost inflation pressures operating margins across segments
- Finnish public contract repricing key to segment margin recovery
| Net Income: 976.0m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.11 > 0.02 and ΔFCF/TA 1.14 > 1.0 |
| NWC/Revenue: -5.01% < 20% (prev -7.26%; Δ 2.25% < -1%) |
| CFO/TA 0.12 > 3% & CFO 2.91b > Net Income 976.0m |
| Net Debt (28.6b) to EBITDA (4.07b): 7.03 < 3 |
| Current Ratio: 0.79 > 1.5 & < 3 |
| Outstanding Shares: last quarter (143.9m) vs 12m ago -4.26% < -2% |
| Gross Margin: 10.23% > 18% (prev 34.53%; Δ -24.31% > 0.5%) |
| Asset Turnover: 75.13% > 50% (prev 75.62%; Δ -0.50% > 0%) |
| Interest Coverage Ratio: 2.53 > 6 (EBIT TTM 2.02b / Interest Expense TTM 796.0m) |
| A: -0.04 (Total Current Assets 3.60b - Total Current Liabilities 4.55b) / Total Assets 25.1b |
| B: 0.04 (Retained Earnings 913.0m / Total Assets 25.1b) |
| C: 0.08 (EBIT TTM 2.02b / Avg Total Assets 25.3b) |
| D: 0.27 (Book Value of Equity 5.29b / Total Liabilities 19.9b) |
| Altman-Z'' = 0.69 = B |
| DSRI: 0.98 (Receivables 1.62b/1.67b, Revenue 19.0b/19.2b) |
| GMI: 3.38 (GM 34.53% / 10.23%) |
| AQI: 1.01 (AQ_t 0.36 / AQ_t-1 0.36) |
| SGI: 0.99 (Revenue 19.0b / 19.2b) |
| TATA: -0.08 (NI 976.0m - CFO 2.91b) / TA 25.1b) |
| Beneish M = -0.90 (Cap -4..+1) = D |
As of August 25, 2026, the stock is trading at SEK 117.70 with a total of 202,599 shares traded. Over the past week, the price has changed by +5.66%, over one month by +7.69%, over three months by +2.88% and over the past year by +74.85%.
Current recommended Stop Loss: 113.80 (which is 3.3% or 1.2 ATR below the current price).
Attendo (publ) has no consensus analysts rating.
P/E Trailing = 17.7005
P/E Forward = 58.4795
P/S = 0.8701
P/B = 3.1419
P/EG = 1.44
Revenue TTM = 19.0b SEK
EBIT TTM = 2.02b SEK
EBITDA TTM = 4.07b SEK
Long Term Debt = 2.98b SEK (from longTermDebt, last fiscal year)
Short Term Debt = 1.69b SEK (from shortTermDebt, last quarter)
Debt = 30.0b SEK (from shortLongTermDebtTotal, last quarter) + Leases 13.3b
Net Debt = 28.6b SEK (calculated: Debt 30.0b - CCE 1.39b)
Enterprise Value = 45.1b SEK (16.5b + Debt 30.0b - CCE 1.39b)
Interest Coverage Ratio = 2.53 (Ebit TTM 2.02b / Interest Expense TTM 796.0m)
EV/FCF = 16.58x (Enterprise Value 45.1b / FCF TTM 2.72b)
FCF Yield = 6.03% (FCF TTM 2.72b / Enterprise Value 45.1b)
FCF Margin = 14.35% (FCF TTM 2.72b / Revenue TTM 19.0b)
Net Margin = 5.14% (Net Income TTM 976.0m / Revenue TTM 19.0b)
Gross Margin = 10.23% ((Revenue TTM 19.0b - Cost of Revenue TTM 17.0b) / Revenue TTM)
Gross Margin QoQ = 9.13% (prev 9.37%)
Tobins Q-Ratio = 1.80 (Enterprise Value 45.1b / Total Assets 25.1b)
Interest Expense / Debt = 2.65% (Interest Expense 796.0m / Debt 30.0b)
Taxrate = 20.62% (254.0m / 1.23b)
NOPAT = 1.60b (EBIT 2.02b * (1 - 20.62%))
Current Ratio = 0.79 (Total Current Assets 3.60b / Total Current Liabilities 4.55b)
Debt / Equity = 5.67 (Debt 30.0b / totalStockholderEquity, last quarter 5.29b)
Debt / EBITDA = 7.03 (Net Debt 28.6b / EBITDA 4.07b)
Debt / FCF = 10.51 (Net Debt 28.6b / FCF TTM 2.72b)
Total Stockholder Equity = 5.39b (last 4 quarters mean from totalStockholderEquity)
RoA = 3.86% (Net Income 976.0m / Total Assets 25.1b)
RoE = 18.11% (Net Income TTM 976.0m / Total Stockholder Equity 5.39b)
RoCE = 24.11% (EBIT 2.02b / Capital Employed (Equity 5.39b + L.T.Debt 2.98b))
RoIC = 7.51% (NOPAT 1.60b / Invested Capital 21.3b)
WACC = 3.54% (E(16.5b)/V(46.5b) * Re(6.16%) + D(30.0b)/V(46.5b) * Rd(2.65%) * (1-Tc(0.21)))
Discount Rate = 6.16% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -99.56 | Cagr: -4.82%
[DCF] Terminal Value 76.76% ; FCFF base≈2.62b ; Y1≈2.86b ; Y5≈3.60b
[DCF] Fair Price = 187.2 (EV 55.1b - Net Debt 28.6b = Equity 26.4b / Shares 141.2m; r=8.35% [WACC [floored]]; 5y FCF grow 10.87% → 2.50% )
EPS Correlation: 98.03 | EPS CAGR: 45.32% | SUE: 3.44 | # QB: 4
Revenue Correlation: 83.08 | Revenue CAGR: 4.49% | SUE: 0.01 | # QB: 0
EPS current Quarter (2026-09-30): EPS=2.39 | Chg30d=+0.42% | Revisions=+0% | Analysts=1
EPS current Year (2026-12-31): EPS=7.39 | Chg30d=+2.28% | Revisions=+25% | GrowthEPS=+22.6% | GrowthRev=+0.2%
EPS next Year (2027-12-31): EPS=8.56 | Chg30d=+4.07% | Revisions=+25% | GrowthEPS=+15.8% | GrowthRev=+4.9%
[Analyst] Revisions Ratio: +40% (up=2, down=0)